Home/Pipeline/GAIA-121 to -125

GAIA-121 to -125

Not Specified (GAAAP-targeted)

PreclinicalActive

Key Facts

Indication
Not Specified (GAAAP-targeted)
Phase
Preclinical
Status
Active
Company

About GAIA BioMedicine

A biotech company developing off-the-shelf, non-genetically modified NK-like cell therapies to eliminate solid tumors.

View full company profile

Therapeutic Areas